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Abstract
Background: Concerns have been raised about low participation rates of people from minority ethnic groups
in clinical trials. However, the evidence is unclear as many studies do not report the ethnicity of participants and
there is insufficient information about the reasons for ineligibility by ethnic group. Where there are data, there
remains the key question as to whether ethnic minorities more likely to be ineligible (e.g. due to language) or
decline to participate. We have addressed these questions in relation to the Birmingham Rehabilitation Uptake
Maximisation (BRUM) study, a randomized controlled trial (RCT) comparing a home-based with a hospital-based
cardiac rehabilitation programme in a multi-ethnic population in the UK.
Methods: Analysis of the ethnicity, age and sex of presenting and recruited subjects for a trial of cardiac
rehabilitation in the West-Midlands, UK.
Participants: 1997 patients presenting post-myocardial infarction, percutaneous transluminal coronary angioplasty
or coronary artery bypass graft surgery.
Data collected: exclusion rates, reasons for exclusion and reasons for declining to participate in the trial by ethnic
group.
Results: Significantly more patients of South Asian ethnicity were excluded (52% of 'South Asian' v 36% 'White
European' and 36% 'Other', p < 0.001). This difference in eligibility was primarily due to exclusion on the basis of
language (i.e. the inability to speak English or Punjabi). Of those eligible, similar proportions were recruited from
the different ethnic groups (white, South Asian and other). There was a marked difference in eligibility between
people of Indian, Pakistani or Bangladeshi origin.
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BMC Medical Research Methodology 2005, 5:18 http://www.biomedcentral.com/1471-2288/5/18Conclusion: Once eligible for this trial, people from different ethnic groups were recruited in similar
proportions. The reason for ineligibility in the BRUM study was the inability to support the range of minority
languages.
Background
Proportional representation of research participants by
race is a requirement of The National Institutes of Health
in the USA [1]. However, no such requirement exists in
the UK, but concern has been expressed about the low rep-
resentation of patients from ethnic minority groups in
clinical trials [2,3]. There are some examples of good prac-
tice with a representative proportion of trial participants
from minority ethnic groups recruited from areas of the
UK with a diverse ethnic population [4,5]. In addition,
there is some evidence that once patients have met the
inclusion criteria for a clinical trial, then equal recruit-
ment of patients from different ethnic groups can be
achieved [6-8].
Much research on ethnicity has focused on testing hypoth-
eses about differences in outcome by race or ethnicity
whilst the issue that participants of trials should represent
the population that will be receiving an intervention has
been relatively neglected. This is essential for the general-
isability of the results [8,9], and to achieve this, trial par-
ticipants need to mirror the demographic profile of the
disease group being studied. Whether participants in trials
of chronic disease management reflect the population
who are affected by such disease is an issue of growing
importance in the UK as the black and minority ethnic
population ages.
There are some unanswered questions with respect to the
low representation of patients from minority ethnic
groups in clinical trials. Firstly, compared to the majority
white population, are patients from ethnic minority
groups less likely to meet the eligibility criteria for a trial
(e.g. because of language)? Secondly, are patients from
ethnic minority groups more likely to refuse to participate
in randomized trials [10]? Birmingham is an excellent
place to explore this issue – some 30% of the population
are from black and minority ethnic groups [11]. We have
the opportunity to address these questions in relation to
the Birmingham Rehabilitation Uptake Maximisation
(BRUM) study, a randomized controlled trial (RCT) com-
paring a home-based with a hospital-based cardiac reha-
bilitation programme in a multi-ethnic population in the
UK [12].
Methods
The BRUM study recruited 525 (26.3%) participants from
the 1997 patients who presented following a myocardial
infarction, percutaneous transluminal coronary angi-
oplasty (PTCA) or coronary artery bypass graft (CABG)
surgery to one of four West Midland hospitals from Feb-
ruary 2002–January 2004 [12]. The hospitals are located
in an area of the UK with a high proportion of people of
South Asian origin. The BRUM study sought to include
patients who spoke either English or Punjabi (which is the
most frequently spoken minority language locally), but
was unable to include patients with other minority lan-
guages because of the lack of validated outcome measures
in these languages.
Basic demographic data including self-defined ethnic
group was sought on all presenting patients. Ethnic status
was recorded using the same categories as the 2001 UK
Census [13]. Data on ethnicity was obtained for 1933
(96.8%) of the patients presenting following a heart
attack, PTCA or CABG, following which the ethnic catego-
ries were then combined into three broad groups: White,
South Asian (Pakistani, Indian and Bangladeshi) and
Other (Caribbean, African, Chinese). No-one described
themselves as being of mixed ethnicity. Data on individ-
ual social class was not collected on all presenting
patients, so postcodes were used to assign the Index of
Multiple Deprivation 2004 (IMD) [14]. Details about the
eligibility of patients, reasons for exclusion from the trial,
and reason for declining to participate were collected.
Data were entered into a Microsoft Windows ACCESS
database (Microsoft Inc, USA) and analysed using SPSS
version 12 (SPSS Inc, Chicago USA). Chi-squared tests
were used to compare proportions across ethnic groups.
For normally distributed data the one-way ANOVA was
used to compare means, and the Kruskal-Wallis test to
compare means for non-parametric data. Logistic regres-
sion was used to determine relative risks of eligibility and
recruitment adjusted for sex, age, deprivation index and
initial diagnosis.
Results
Table 1 details the proportion of patients excluded and
the reasons given. Reasons for non-recruitment are
divided into exclusion criteria (e.g. language, severe dis-
ease, co-morbidity) and refusal. Significantly more South
Asian patients were excluded (51.9%), but mainly for the
reason of language (24.3%). Exclusions for co-morbidity
were lowest in the South Asian patients (6.8% v 12.1% of
white ethnic group), probably as a result of their signifi-
cantly lower mean age (see table 1).Page 2 of 6
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BMC Medical Research Methodology 2005, 5:18 http://www.biomedcentral.com/1471-2288/5/18Table 1: Recruitment to and exclusion from the BRUM trial, by ethnic group
White South Asian Other fp-value
All presenting, n 1452 412 69
MI n (%) 811 (56.4) 230 (56.5) 42 (61.8) 0.6
PTCA n (%) 514 (35.7) 149 (36.6) 19 (27.9)
CABG n (%) 113 (7.9) 28 (6.9) 7 (10.3)
Mean (SD) age 66.3 (12.0) 61.0 (12.4) 66.5 (12.2) <0.001
Males n (%) 998 (68.9) 311 (75.5) 47 (69.1) 0.04
Mean (SD) Index of Multiple Deprivation (IMD) [14] 32.9 (17.1) 43.7 (16.6) 48.3 (16.8) <0.001
Excluded n (%) 525 (36.1) 214 (51.9) 25 (36.2) <0.001
Reason for exclusion (more than 1 may apply) n (%)
aLanguage 4 (0.30) 120 (29.4) 3 (4.5) <0.001
bHigh cardiac risk 191 (13.2) 50 (12.1) 6 (8.7) 0.7
cComorbidity 175 (12.1) 28 (6.8) 6 (8.7) 0.01
In other trial 18 (1.2) 6 (1.5) 2 (2.9) 0.7
Out of area 76 (5.2) 18 (4.4) 2 (2.9) 0.4
dSensory deficit 37 (2.5) 8 (1.9) 1 (1.4) 0.6
eMental health 41 (2.8) 6 (1.5) 5 (7.2) 0.06
Deceased 19 (1.3) 5 (1.2) 0 (0) 0.6
Excluded for language only n (%) 2 (0.1) 100 (24.3) 3 (4.35) <0.001
Eligible n (% of all presenting) 927 (63.8) 198 (48.1) 44 (63.8) <0.001
Males (% of presenting males) 659 (65.7) 163 (52.4) 32 (68.0)
Female (% presenting females) 268 (59.0) 35 (34.7) 12 (54.6)
Mean (SD) IMD of eligible patients 32.3 (16.6) 41.2 (16.7) 47.1 (17.3) <0.001
Refused (% of eligible) 514 (55.4) 109 (55.1) 27 (61.4) 0.2
Reason for refusal: n (%)
Did not want rehabilitation 85 (16.5) 10 (9.2) 3 (11.1)
Did not want to take part in research 272 (52.9) 38 (34.9) 11 (40.7)
Preference for hospital programme 62 (12.1) 15 (13.8) 3 (11.1)
No reason given 95 (18.5) 46 (42.2) 10 (37.0) <0.001
Total recruited (% of eligible) 418 (45.1) 88 (44.4) 19 (43.2) 0.7
(% of all) (28.8) (21.4) (21.3)
Males (% of eligible males) 312 (47.3) 76 (46.6) 14 (43.8)
Female (% of eligible females) 106 (39.6) 12 (34.3) 5 (41.7)
Mean (SD) IMD of recruited patients 31.6 (15.7) 40.0 (16.9) 47.0 (15.2) <0.001
aLanguage: unable to speak English or Punjabi, or Punjabi speaking nurse not available to recruit the patient.
bHigh risk: patients with risk factors excluding a home-based cardiac rehabilitation programme, e.g. severe angina, hart failure or documented 
arrhythmias.
cComorbidity: physical conditions which would interfere with the ability to undertake a cardiac rehabilitation programme, e.g. severe arthritis, 
malignancy.
dSensory deficit: severe hearing or visual loss such that patients would not be able to read written materials or communicate with research nurses 
on the telephone.
eMental health: patients with case-note documented dementia or current mental illness.
fChi square test (except for age comparison, oneway ANOVA; index of deprivation comparison, Kruskal-Wallis test)Page 3 of 6
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(95% CI) for eligibility was 0.42 (0.33, 30.55) for South
Asians (table 2). However, there were no significant eth-
nic differences in the proportion of eligible patients
recruited to the trial (45.1% of whites, 44.6% of South
Asians, see Table 1). Compared with the British white eth-
nic group, the relative risk of recruitment of eligible
patients was 0.59 (0.44, 0.78) for South Asians, when
adjusted for age, gender, deprivation index and initial
diagnosis.
In each ethnic group (white, South Asian and other)
women were less likely to be eligible for the study than
men (table 1). This was statistically significant for the
white and South Asian groups. Overall the women pre-
senting with ischaemic heart disease were significantly
older than the men (mean age 69.2 versus 63.6 years for
men, p = 0.002) and were more likely to be excluded
because of co-morbidity (16.8% v 8.6% of men, p <
0.001). Women of white and South Asian ethnicity were
significantly less likely than the men of these ethnic
groups to be recruited once eligible (p < 0.01) (table 1).
There was no difference given in the reasons for declining
to participate in the study by men and women.
The reasons for and rates of exclusion varied markedly
between the three main South Asian groups, with exclu-
sion rates of 29%, 63% and 70% among people of Indian,
Pakistani and Bangladeshi origin respectively (Table 3).
Figures for exclusions due to language barriers ranged
from 5.1% (Indian) to 55% (Bangladeshi). In each South
Asian sub-group the exclusion rate for language barriers
was higher in people aged 65 years or more with 8.2% of
people of Indian ethnicity, 43.6% of Pakistani and 87.5%
of people of Bangladeshi ethnicity aged 65 years or more
excluded because of language. This was approximately
double the exclusion rates in people aged less than 65
years (see Table 3). A similar picture emerges for women,
with higher exclusion rates for women in each of the
South Asian sub-groups. Compared to people of white
British origin, people of Pakistani and Bangladeshi origin
were at a 4-fold increased risk of ineligibility to the trial,
whilst people of Indian ethnicity were no more likely to
be ineligible (see Table 3).
Discussion
This report has detailed the process of recruitment to a
randomized controlled trial for patients from different
ethnic groups from presentation with a cardiac event,
through the eligibility criteria and consent process.
We have demonstrated that the point of inequality in
recruitment between ethnic groups in this study occurred
because of an inability to support the range of minority
languages. This was despite additional measures
employed to recruit Punjabi speaking patients, including
a Punjabi speaking research nurse, translated (and
recorded) patient information and the translation and
validation of the Hospital Anxiety and Depression Scale
into Punjabi. It is possible that those excluded on the
grounds of language would have refused to participate in
the trial, but we have no evidence to support or refute this
possibility. Of those excluded as a result of language, 74%
described themselves as of Pakistani origin and thus
would have been catered for by the provision of Urdu and
Mirapuri (an oral only language used by people of rural
Pakistani origin). The socio-economic status of the pre-
senting patients this is clearly a potential confounding fac-
tor, with people from minority ethnic groups who do not
speak English being more likely to be of lower socio-eco-
nomic status [15]. Presenting patients from minority eth-
nic groups had significantly higher deprivation indices
than the white ethnic group, using the IMD as a measure
of socio-economic status, in this study. Whilst the level of
deprivation was a significant factor in the multiple regres-
sion analysis, ethnicity was still a significant factor in the
likelihood of eligibility and recruitment to the trial when
deprivation was included in the regression model.
Table 2: Eligibility and recruitment BRUM by ethnicity, adjusted for age, sex, deprivation and initial diagnosis
Ethnic group Adjusted RRa of 
eligibility
95% CI Adjusted RR of 
recruitment
95% CI
White British 1.00 (base) 1.00 (base)
Other White 1.52 0.81 to 2.84 01.10 0.60 to 2.02
South Asian 0.42* 0.33 to 0.55 0.59* 0.44 to 0.78
Afro-Caribbean 1.28 0.70 to 2.35 1.03 0.54 to 2.00
Other 0.86 0.16 to 4.19 0.97 0.23 to 4.21
White British used as the reference group (RR = 1.0)
aRR: relative risk
*P < 0.001Page 4 of 6
(page number not for citation purposes)
BMC Medical Research Methodology 2005, 5:18 http://www.biomedcentral.com/1471-2288/5/18We found no significant differences in the proportions of
people from the three main ethnic groups who gave the
reason for their refusing to participate as 'not wishing to
take part in research.' This result differs from the evidence
from the USA, which suggests that people from minority
ethnic groups are less likely to agree to participate in clin-
ical research because of a lack of trust [16]. The UK does
not have the past history of the Tuskegee Syphilis study
which appears to be the cause of this mistrust of research
in black and minority ethnic groups in the US [17,18]. It
is true that in this study a higher proportion of the minor-
ity ethnic groups who declined to participate in the trial
gave no reason for their decision, so it is possible that
there were differences in the reasons for not-participating
that we failed to identify.
In addition, our findings provide further support for the
limited evidence base that patients from ethnic minority
groups can be recruited in a similar proportion to the
majority population, once they have fulfilled the trial's
eligibility criteria [7,8]. Other studies have tried to retro-
spectively estimate the proportion of patients from differ-
ent ethnic groups, who would have been potential trial
participants [19]. However, we believe that this is the first
published report that has detailed the whole recruitment
process of cardiac patients presenting with the index con-
ditions, reasons for ineligibility and rates and reasons for
refusal to participate. In the BRUM trial, the eligible
patients of South Asian ethnicity were no more likely to
decline to participate on the grounds of not wishing to
take part in a research study than other ethnic groups.
Conclusion
This research raises the issue of feasibility versus inclusiv-
ity. In this study, even with considerable effort, time and
resources to try to recruit a representative population to










Mean (SD) age, years 61.0 (12.6) 61.0 (12.4) 63.1 (7.3)
Males n, (%) 96 (70.6) 184 (77.3) 15 (75)
Mean (SD) IMD score 35.95 (15.8) 47.8 (15.7) 48.9 (14.4)
Any exclusion 40 (29.4) 151 (63.4) 14 (70)
Reason for exclusion (more than one may apply) n (%)
aLanguage 10 (7.5) 94 (39.8) 11 (55)
bHigh cardiac risk 15 (11) 33 (13.9) 1 (5)
cComorbidity 8 (5.9) 19 (8.0) 0 (0)
Excluded for language only: 1
All n (%) 7 (5.1) 78 (32.8) 1 (55)
Aged <65 years 3 (3.4) 34 (24.8) 4 (40)
65+ 4 (8.2) p = 0.2 44 (43.6) p = 0.002 7 (87.5) p = 0.2
Gender males 4 (4.2) 51 (27.7) 6 (40)
females 3 (7.5) p = 0.4 27 (50) p = 0.003 5 (100) p = 0.04
Total recruited n 50 31 4
(% of eligible) (52.1) (35.6)
(% of all presenting) (36.8) (13) (20)
RR of ineligibility (95%CI)* 0.89 (0.6, 1.3) 4.0 (2.9, 5.5) 4.4 (1.6, 11.8)
aLanguage: unable to speak English or Punjabi, or Punjabi speaking nurse not available to recruit the patient.
bHigh risk: patients with risk factors excluding a home-based cardiac rehabilitation programme, e.g. severe angina, heart failure or documented 
arrhythmias.
cComorbidity: physical conditions which would interfere with the ability to undertake a cardiac rehabilitation programme, e.g. severe arthritis, 
malignancy.
SD: standard deviation
*adjusted for age, sex and deprivation index using white British as the reference group (RR = 1.0)Page 5 of 6
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the trial, we were unable to meet the wide language
requirements. This must be considered in the context that
this was a trial of a behavioural intervention with a psy-
chological questionnaire as a main outcome measure. In
other trials, with only objective clinical measurements as
endpoints, it might be possible to exclude less patients
due to language restrictions. In a geographical area of eth-
nic diversity, a number of languages would need to be
supported to achieve equivalent recruitment rates for dif-
ferent ethnic groups, which has considerable cost and
methodological implications. The importance of achiev-
ing a sample that is ethnically representative will depend
on the research question and the context.
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